Dufour D, Zhao X, Chaleil F, Nothnagel P, Bjoras M, Lefrancois-Martinez A
Adipocyte. 2025; 14(1):2474107.
PMID: 40047287
PMC: 11901380.
DOI: 10.1080/21623945.2025.2474107.
Wang J, Zhang R, Wu C, Wang L, Liu P, Li P
Front Pharmacol. 2024; 15:1432724.
PMID: 39431155
PMC: 11486755.
DOI: 10.3389/fphar.2024.1432724.
Wu Y, Sun Y, Song Y, Wang J, Han Y, Yang N
Cell Death Differ. 2024; 31(8):1044-1056.
PMID: 38762596
PMC: 11303681.
DOI: 10.1038/s41418-024-01309-2.
Kim M, Baek J, Lee J, Sivaraman A, Lee K, Chun K
Cell Death Dis. 2023; 14(11):776.
PMID: 38012162
PMC: 10681981.
DOI: 10.1038/s41419-023-06317-7.
Nakano T, Sasaki Y, Norikura T, Hosokawa Y, Kasano M, Matsui-Yuasa I
Food Sci Nutr. 2023; 11(10):6151-6163.
PMID: 37831750
PMC: 10563708.
DOI: 10.1002/fsn3.3551.
SENP2 knockdown in human adipocytes reduces glucose metabolism and lipid accumulation, while increases lipid oxidation.
Krapf S, Lund J, Bakke H, Nyman T, Bartesaghi S, Peng X
Metabol Open. 2023; 18:100234.
PMID: 37013149
PMC: 10066554.
DOI: 10.1016/j.metop.2023.100234.
Loss of SUMO-specific protease 2 causes isolated glucocorticoid deficiency by blocking adrenal cortex zonal transdifferentiation in mice.
Dufour D, Dumontet T, Sahut-Barnola I, Carusi A, Onzon M, Pussard E
Nat Commun. 2022; 13(1):7858.
PMID: 36543805
PMC: 9772323.
DOI: 10.1038/s41467-022-35526-5.
Discovery of a Dual SENP1 and SENP2 Inhibitor.
Brand M, Bommeli E, Rutimann M, Lindenmann U, Riedl R
Int J Mol Sci. 2022; 23(20).
PMID: 36292935
PMC: 9602571.
DOI: 10.3390/ijms232012085.
Large-Scale Multi-Omics Studies Provide New Insights into Blood Pressure Regulation.
Kamali Z, Keaton J, Javanmard S, International Consortium Of Blood Pressure , Program M, eQTLGen Consortium
Int J Mol Sci. 2022; 23(14).
PMID: 35886906
PMC: 9323755.
DOI: 10.3390/ijms23147557.
Waves of sumoylation support transcription dynamics during adipocyte differentiation.
Zhao X, Hendriks I, Le Gras S, Ye T, Ramos-Alonso L, Nguea P A
Nucleic Acids Res. 2022; 50(3):1351-1369.
PMID: 35100417
PMC: 8860575.
DOI: 10.1093/nar/gkac027.
The cross-talk between PARylation and SUMOylation in C/EBPβ at K134 site participates in pathological cardiac hypertrophy.
Wang L, Wang P, Xu S, Li Z, Duan D, Ye J
Int J Biol Sci. 2022; 18(2):783-799.
PMID: 35002525
PMC: 8741850.
DOI: 10.7150/ijbs.65211.
The protease SENP2 controls hepatic gluconeogenesis by regulating the SUMOylation of the fuel sensor AMPKα.
Dou X, Zhou W, Ding M, Ma Y, Yang Q, Qian S
J Biol Chem. 2021; 298(2):101544.
PMID: 34971706
PMC: 8888337.
DOI: 10.1016/j.jbc.2021.101544.
SENP2 is vital for optimal insulin signaling and insulin-stimulated glycogen synthesis in human skeletal muscle cells.
Lund J, Krapf S, Sistek M, Bakke H, Bartesaghi S, Peng X
Curr Res Pharmacol Drug Discov. 2021; 2:100061.
PMID: 34909683
PMC: 8663970.
DOI: 10.1016/j.crphar.2021.100061.
Not So Slim Anymore-Evidence for the Role of SUMO in the Regulation of Lipid Metabolism.
Sapir A
Biomolecules. 2020; 10(8).
PMID: 32781719
PMC: 7466032.
DOI: 10.3390/biom10081154.
Peroxiredoxin 4 inhibits insulin-induced adipogenesis through regulation of ER stress in 3T3-L1 cells.
Kim J, Kim M, Lee H, Huh J, Lee S, Lee H
Mol Cell Biochem. 2020; 468(1-2):97-109.
PMID: 32185676
DOI: 10.1007/s11010-020-03714-w.
Nlrp1b1 negatively modulates obesity-induced inflammation by promoting IL-18 production.
Salazar-Leon J, Valdez-Hernandez A, Garcia-Jimenez S, Roman-Dominguez L, Huanosta-Murillo E, Bonifaz L
Sci Rep. 2019; 9(1):13815.
PMID: 31554824
PMC: 6761090.
DOI: 10.1038/s41598-019-49546-7.
SUMO-specific protease 2 mediates leptin-induced fatty acid oxidation in skeletal muscle.
Do Koo Y, Lee J, Lee S, Quaresma P, Bhat R, Haynes W
Metabolism. 2019; 95:27-35.
PMID: 30902749
PMC: 7398119.
DOI: 10.1016/j.metabol.2019.03.004.
Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk.
Christodoulou M, Avgeris M, Kokkinopoulou I, Maratou E, Mitrou P, Kontos C
Sci Rep. 2019; 9(1):1512.
PMID: 30728419
PMC: 6365563.
DOI: 10.1038/s41598-018-37856-1.
Ginkgolic acid, a sumoylation inhibitor, promotes adipocyte commitment but suppresses adipocyte terminal differentiation of mouse bone marrow stromal cells.
Liu H, Li J, Lu D, Li J, Liu M, He Y
Sci Rep. 2018; 8(1):2545.
PMID: 29416046
PMC: 5803256.
DOI: 10.1038/s41598-018-20244-0.
A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.
Ajorloo F, Vaezi M, Saadat A, Safaee S, Gharib B, Ghanei M
PLoS One. 2017; 12(9):e0183969.
PMID: 28892521
PMC: 5593188.
DOI: 10.1371/journal.pone.0183969.